Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001032210-02-000367
Filing Date
2002-03-11
Accepted
2002-03-11 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1144515
3 CONSULTING AGREEMENT WITH DAVID COLLINS dex1090.htm EX-10.90 31490
4 THIRD ADDENDUM TO LEASE WITH GEE-ASPORA LLC dex1091.htm EX-10.91 29557
5 FORM OF COMMON STOCK PURCHASE AGMT DATED 11/13/01 dex10109.htm EX-10.109 44681
6 FORM OF COMMON STOCK PURCHASE AGMT DATED 2/12/02 dex10110.htm EX-10.110 61280
7 CONSENT OF KPMG LLP dex231.htm EX-23.1 2854
  Complete submission text file 0001032210-02-000367.txt   1316512
Mailing Address 1265 HARBOR BAY PKWY ALAMEDA CA 94502
Business Address 1265 HARBOR BAY PARKWAY ALAMEDA CA 94502- 5107495100
CALYPTE BIOMEDICAL CORP (Filer) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20985 | Film No.: 02572586
SIC: 3826 Laboratory Analytical Instruments